Study of ASTX727 and Donor Lymphocyte Infusions for Patients with High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia After Stem Cell Transplant
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on the Effectiveness of Olaparib for Patients with Advanced Cancers and Specific Genetic Mutations
Not recruiting
Investigated Drugs:
Study Comparing CPX-351 and Conventional Drug Combination for Patients with High-Risk Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia Before Stem Cell Transplant
Not recruiting
Investigated Diseases:Investigated Drugs:
powered by
